Because of challenges in making the correct diagnosis and the physician’s reluctance to administer chemotherapy for a disease characterized by such a low tumoral mass, patients may experience a delay in the initiation of appropriate treatment.
Arnaud Jaccard, MD, PhD
Advertisement
Articles by Arnaud Jaccard, MD, PhD
Advertisement
Latest Updated Articles
- POEMS Syndrome: Still an Enigma?
Published: December 15th 2013 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Belzutifan Plus Lenvatinib Improves PFS/ORR in Advanced Pretreated RCC
2
Response Rates Show Promise in Phase 1 trial Involving ASCT in Metastatic PDAC
3
What Path to Approval Has Dasatinib Taken in CML/ALL?
4
JSKN003 Receives FDA Fast Track Designation in Advanced PROC
5
